within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J07C_BacterialAndViralVaccinesCombined.J07CA04_HaemophilusInfluenzaeBAndPoliomyelitis;
model HaemophilusInfluenzaeBAndPoliomyelitis 
   extends Pharmacolibrary.Drugs.ATC.J.J07CA04;

  annotation(Documentation(
    info ="<html><body><p>This combination vaccine contains purified polysaccharide conjugate of Haemophilus influenzae type B (Hib) and polioviruses (inactivated), used for the prevention of invasive diseases caused by H. influenzae type B and poliomyelitis infection. It is widely used and approved for immunization in infants and children.</p><h4>Pharmacokinetics</h4><p>No pharmacokinetic (PK) data as such is available for this vaccine combination because vaccines are not characterized by traditional small-molecule PK parameters. Most available data are on immunogenicity and serological responses in infants and children.</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end HaemophilusInfluenzaeBAndPoliomyelitis;
